We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Measures include constant monitoring of the drug’s usage and ensuring its uninterrupted supply by working in collaboration with healthcare practitioners and regulators.
The company informed that central and state regulatory authorities have carried out an inspection of its API manufacturing site in Vadodara, formulation facility likely to get inspected.